GCTAX
Price
$49.11
Change
+$0.23 (+0.47%)
Updated
Aug 8 closing price
Net Assets
4.15B
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

GCTAX vs VSTSX

Header iconGCTAX vs VSTSX Comparison
Open Charts GCTAX vs VSTSXBanner chart's image
Goldman Sachs US Tax-Managed Eq A
Price$49.11
Change+$0.23 (+0.47%)
VolumeN/A
Net Assets4.15B
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
GCTAX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCTAX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTAX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. GCTAX (4.15B). VSTSX pays higher dividends than GCTAX: VSTSX (1.20) vs GCTAX (0.11). GCTAX was incepted earlier than VSTSX: GCTAX (25 years) vs VSTSX (9 years). GCTAX (1.05) is less costly to investors than VSTSX (0.01). GCTAX is a more actively managed with annual turnover of: 96.00 vs. VSTSX (2.00). GCTAX has a lower initial minimum investment than VSTSX: GCTAX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 19.70 vs. GCTAX (16.18). VSTSX (85.11) and GCTAX (83.56) have equivalent 5 years return.
GCTAXVSTSXGCTAX / VSTSX
Total Expense Ratio1.010.0110,100%
Annual Report Gross Expense Ratio1.050.0110,500%
Fund Existence25 years9 years-
Gain YTD5.7558.08871%
Front Load6%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.15B1.91T0%
Annual Yield % from dividends0.111.209%
Returns for 1 year16.1819.7082%
Returns for 3 years52.4952.05101%
Returns for 5 years83.5685.1198%
Returns for 10 years185.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited